SBI Healthcare Opportunities Fund - Regular Plan -Growth
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 14-07-1999
AUM:
₹ 3,989.42 Cr
Expense Ratio
1.93%
Benchmark
BSE Healthcare TRI
ISIN
INF200K01446
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
500
Fund Manager
Mr. Tanmaya Desai,
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| SBI Healthcare Opportunities Fund - Regular Plan -Growth | 0.88 | 23.58 | 15.77 |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
421.1063
Last change
0.95 (0.2256%)
Fund Size (AUM)
₹ 3,989.42 Cr
Performance
15.15% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
To provide the investors with the opportunity of long term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Fund Manager
Mr. Tanmaya Desai,
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 11.64 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 7.05 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 5.24 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 4.44 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 3.89 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 3.86 |
| Ami Organics Limited | 3.85 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 3.79 |
| Lonza Group | 3.63 |
| TREPS | 3.51 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 88.93 |
| Chemicals | 3.02 |
| Consumer Services | 1.01 |